Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron, early functional recovery and delirium in hip fracture
2014-001923-53Phase 4Active
- Sponsor
- Rafael Bielza Galindo
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of iron sucrose in hip fracture, postoperative delirium (POD) and functional disability (2 arms), sponsored by Rafael Bielza Galindo. Primary endpoints: Incidence of postoperative delirium and Functional gain (Barthel scale change). Started Jul 2015; status: active.
02
Drugs
iron sucrose
03
Conditions
hip fracturepostoperative delirium (POD)functional disability
Beyond the preview
Go deeper on 2014-001923-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001923-53.